Equine cIV antibody and antigen (recombinant protein)

Diagnostic anti-Equine cIV antibodies pairs and antigen for animal health (animal Equine/Horse Goodpasture syndrome, Alport syndrome,  glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.  porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-cIV-Ag01Equine cIV$3090.00
GMP-EQU-cIV-Ab01Anti-Equine cIV mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-cIV-Ab02Anti-Equine cIV mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-cIV-Ab03Anti-Equine cIV human monoclonal antibody (mAb)$3090.00
GMP-EQU-cIV-Ab04Anti-Equine cIV human monoclonal antibody (mAb)$3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-cIV-Ag01
Product NameEquine cIV
Target/BiomarkerEquine cIV
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine cIV antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome,  glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.  porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury..
TagHis
Reconized/Reactive SpecicsEquine cIV
Product descriptionRecombinant Equine cIV protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-cIV-Ab01,GMP-EQU-cIV-Ab02
Target/BiomarkerEquine cIV
Product NameAnti-Equine cIV mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine cIV antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies in Equine cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome,  glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.  porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury..
Product descriptionAnti-Equine cIV mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-cIV-Ab03,GMP-EQU-cIV-Ab04
Target/BiomarkerEquine cIV
Product NameAnti-Equine cIV human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine cIV antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies in Equine cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome,  glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.  porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury..
Product descriptionAnti-Equine cIV mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine Collagen Type IV (cIV) emerges as a silent sentinel within the expansive tapestry of equine biology, a master of structural integrity that quietly fortifies the extracellular matrix. As a member of the collagen family, cIV boasts a triple helical structure composed of three distinct polypeptide chains—a configuration that marries strength with flexibility, ideal for its role as the cornerstone of basement membranes.

    Basement membranes are far from passive foundations; they are bustling centers of cellular orchestration. cIV, at their core, offers not just architectural support but active participation in molecular signaling. Within basement membranes, cIV engages in intricate interplay with an ensemble of proteins and signaling molecules. This intricate web shapes a landscape where cellular adhesion, migration, growth, and differentiation are finely choreographed.

    Imagine cIV as the conductor of a symphony, ensuring harmonious cellular interactions, safeguarding structural stability, and orchestrating a molecular ballet that regulates vital physiological processes. Its role extends beyond the mechanical; it bridges the physical and molecular worlds, an architect and a communicator.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.